Navigation Links
Intendis, Inc. Changes Name to Bayer HealthCare
Date:1/4/2012

MORRISTOWN, N.J., Jan. 4, 2012 /PRNewswire/ -- Five years after being acquired by Bayer, Intendis, Inc., makers of dermatology brands Finacea® (azelaic acid) Gel, 15% and Desonate® (desonide) Gel 0.05%, will change its name to Bayer HealthCare.  Under this new name, the unit will continue to build on Intendis' long-standing dedication to dermatologists, patients and passion for skin health.

"Although Intendis, Inc. will have a new name and a new look, the company's pioneering tradition in dermatology remains at the heart of everything we do," said Bill Griffing, U.S. President and General Manager for Bayer HealthCare's Dermatology Unit. "During the past five years, we have focused on bringing together the best of both Intendis, Inc. and Bayer HealthCare to better serve our customers. Clarifying our place in the Bayer family with this name change increases our access to talented experts and resources that will allow us to continue to develop new therapies to improve skin health and the lives of patients with skin conditions."

While all Intendis, Inc. branding will be changed to reflect the Bayer brand, there will be no changes in the well-established organization, structure, or product quality of the company. The points of contact assisting physicians, pharmacists and partner companies remain the same. Intendis, Inc. has been an integrated part of the Bayer organization's Consumer Care division since 2006, when Bayer acquired Schering AG. 

"The name change from Intendis, Inc. to Bayer HealthCare represents a larger shift in our company's model - from a focus on products, to a broader, more value-based approach in healthcare," said Griffing. "We remain committed to both of our products Finacea® (azelaic acid) Gel, 15% and Desonate® (desonide) Gel 0.05% - and to finding ways to bring new advancements to market using Bayer's extensive R&D capabilities."

About Bayer HealthCare's Dermatology Unit
Bayer HealthCare's Dermatology Unit is a specialized global pharmaceutical company focused solely in dermatology. It is headquartered in Berlin, and was founded in 2005 as a subsidiary of Schering AG, Germany. Today, Dermatology is part of the Bayer Group with commercial operations around the globe. The affiliate in the United States is headquartered in Morristown, NJ, and currently offers the following products:  Finacea® (azelaic acid) Gel, 15% and Desonate® (desonide) Gel 0.05%.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of healthcare, nutrition and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of more than EUR 16.9 billion (2010), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover and manufacture products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 55,700 employees and is represented in more than 100 countries. Find more information at www.bayerhealthcare.com.

Contact:
Kate Fisher, 212 880 5204
E-Mail: kate.fisher@ogilvy.com

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no obligation whatsoever to update these forward-looking statements or to adjust them to include future events or developments.


'/>"/>
SOURCE Bayer HealthCare
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Adaptive TCR Changes Name to Adaptive Biotechnologies
2. Chindex International, Inc. Announces Management Changes
3. New Management Changes Poise USANA for Further Growth
4. Concord Medical Announces Shareholder Resolutions Adopted at 2011 Annual General Meeting, Board and Management Changes
5. Dehaier Medical Announces Changes to Board of Directors
6. Max Healthcare Announces Organizational Changes
7. Proposed CMS Changes Related to Consultant Pharmacists Raise Profound Concerns for Pharmacies
8. WaferGen Announces Organizational Changes to Enhance Commercialization of SmartChip System
9. Lilly Announces Changes in Senior Management
10. China Biologic Announces Changes in Directors
11. FDA Announces Changes in Drug Centers Oncology Office
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)...  MedSource announced today that it has selected ... of choice.  This latest decision demonstrates MedSource,s commitment ... clients by offering a state-of-the-art electronic data capture ... as the EDC platform of choice in exchange ... has long been a preferred EDC platform by ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of ... award to iHire in recognition of their exemplary accomplishments in worksite health promotion. , ... Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was ...
(Date:6/24/2016)... ... , ... Those who have experienced traumatic events may suffer from a complex ... as drug or alcohol abuse, as a coping mechanism. To avoid this pain and ... a traumatic event. , Trauma sufferers tend to feel a range of emotions, from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Comfort Keepers® of ... Cancer Society and the Road To Recovery® program to drive cancer patients to and ... other adults to ensure the highest quality of life and ongoing independence. Getting ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine ... Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor ... Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With this ...
Breaking Medicine News(10 mins):